BDX Q1 2022 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.7B-11.2% YoY

Gross Profit

$2.2B47.1% margin

Operating Income

$692M14.7% margin

Net Income

$677M14.3% margin

EPS (Diluted)

$2.28

QoQ Revenue Growth

-8.1%

Cash Flow

Operating Cash Flow

$674M

Free Cash Flow

$486M

Stock-Based Comp.

$83M

Balance Sheet

Total Assets

$53.4B

Total Liabilities

$29.2B

Stockholders' Equity

$24.2B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.7B	$5.3B	-11.2%
Gross Profit	$2.2B	$2.7B	-18.7%
Operating Income	$692M	$1.2B	-44.2%
Net Income	$677M	$1.0B	-32.5%

Revenue Segments

Medical

$2.4B48%

Life Sciences

$1.5B30%

Interventional

$1.1B22%

Geographic Segments

UNITED STATES

$2.9B57%

Non-US

$2.1B43%